| Long-term toxicity of cisplatin in germ-cell tumor survivors M Chovanec, MA Zaid, N Hanna, N El-Kouri, LH Einhorn, C Albany Annals of Oncology 28 (11), 2670-2679, 2017 | 184 | 2017 |
| Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors Z Cierna, M Mego, V Miskovska, K Machalekova, M Chovanec, ... Annals of oncology 27 (2), 300-305, 2016 | 145 | 2016 |
| Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium S Gillessen, N Sauvé, L Collette, G Daugaard, R de Wit, C Albany, ... Journal of Clinical Oncology 39 (14), 1563-1574, 2021 | 142 | 2021 |
| Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-update consortium J Beyer, L Collette, N Sauvé, G Daugaard, DR Feldman, T Tandstad, ... Journal of clinical oncology 39 (14), 1553-1562, 2021 | 111 | 2021 |
| Systemic immune-inflammation index in germ-cell tumours M Chovanec, Z Cierna, V Miskovska, K Machalekova, K Kalavska, ... British journal of cancer 118 (6), 831-838, 2018 | 83 | 2018 |
| Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors C Albany, N Adra, AC Snavely, C Cary, TA Masterson, RS Foster, ... Annals of Oncology 29 (2), 341-346, 2018 | 76 | 2018 |
| Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors M Chovanec, Z Cierna, V Miskovska, K Machalekova, D Svetlovska, ... Oncotarget 8 (13), 21794, 2017 | 70 | 2017 |
| Long-term cognitive dysfunction in cancer survivors Z Országhová, M Mego, M Chovanec Frontiers in molecular biosciences 8, 770413, 2021 | 69 | 2021 |
| Clinical utility of plasma miR‐371a‐3p in germ cell tumors M Mego, T van Agthoven, P Gronesova, M Chovanec, V Miskovska, ... Journal of cellular and molecular medicine 23 (2), 1128-1136, 2019 | 67 | 2019 |
| Management of stage I testicular germ cell tumours Michal Chovanec, Nasser Hanna, K. Clint Cary, Lawrence Einhorn, Costantine ... Nature Reviews Urology, 2016 | 66 | 2016 |
| PARP expression in germ cell tumours M Mego, Z Cierna, D Svetlovska, D Macak, K Machalekova, V Miskovska, ... Journal of clinical pathology 66 (7), 607-612, 2013 | 63 | 2013 |
| Phase II study of everolimus in refractory testicular germ cell tumors M Mego, D Svetlovska, V Miskovska, J Obertova, P Palacka, J Rajec, ... Urologic Oncology: Seminars and Original Investigations 34 (3), 122. e17-122 …, 2016 | 58 | 2016 |
| Phase II study of avelumab in multiple relapsed/refractory germ cell cancer M Mego, D Svetlovska, M Chovanec, M Rečkova, K Rejlekova, J Obertova, ... Investigational new drugs 37, 748-754, 2019 | 53 | 2019 |
| Maintenance of genome stability: the unifying role of interconnections between the DNA damage response and RNA-processing pathways B Mikolaskova, M Jurcik, I Cipakova, M Kretova, M Chovanec, L Cipak Current genetics 64, 971-983, 2018 | 53 | 2018 |
| Late adverse effects and quality of life in survivors of testicular germ cell tumour M Chovanec, J Lauritsen, M Bandak, C Oing, GG Kier, M Kreiberg, ... Nature Reviews Urology 18 (4), 227-245, 2021 | 50 | 2021 |
| Immunotherapy in testicular germ cell tumors K Kalavska, S Schmidtova, M Chovanec, M Mego Frontiers in Oncology 10, 573977, 2020 | 37 | 2020 |
| Disulfiram overcomes cisplatin resistance in human embryonal carcinoma cells S Schmidtova, K Kalavska, K Gercakova, Z Cierna, S Miklikova, ... Cancers 11 (9), 1224, 2019 | 37 | 2019 |
| Long‐term cognitive functioning in testicular germ‐cell tumor survivors M Chovanec, L Vasilkova, L Setteyova, J Obertova, P Palacka, ... The Oncologist 23 (5), 617-623, 2018 | 37 | 2018 |
| The impact of the microbiome on resistance to cancer treatment with chemotherapeutic agents and immunotherapy A Sevcikova, N Izoldova, V Stevurkova, B Kasperova, M Chovanec, ... International Journal of Molecular Sciences 23 (1), 488, 2022 | 36 | 2022 |
| Advances in diagnosis and treatment of testicular cancer M Chovanec, L Cheng bmj 379, 2022 | 35 | 2022 |
Costantine AlbanyIndiana UniversityBestätigte E-Mail-Adresse bei iu.edu
